par Vergison, Anne 
;Denis, Olivier ;Deplano, Ariane ;Casimir, Georges ;Claeys, Geert;DeBaets, F.;Deboeck, Kris;Douat, Nicole ;Franckx, Hilde;Gigi, Jacques;Ieven, Margaretha;Knoop, Christiane ;Lebeque, P.;Lebrun, Fabienne;Malfroot, Anne;Paucquay, F.;Pierard, Denis;Vaneldere, Johan Van;Struelens, Marc
Référence Journal of antimicrobial chemotherapy, 59, 5, page (893-899)
Publication Publié, 2007-05
;Denis, Olivier ;Deplano, Ariane ;Casimir, Georges ;Claeys, Geert;DeBaets, F.;Deboeck, Kris;Douat, Nicole ;Franckx, Hilde;Gigi, Jacques;Ieven, Margaretha;Knoop, Christiane ;Lebeque, P.;Lebrun, Fabienne;Malfroot, Anne;Paucquay, F.;Pierard, Denis;Vaneldere, Johan Van;Struelens, Marc Référence Journal of antimicrobial chemotherapy, 59, 5, page (893-899)
Publication Publié, 2007-05
Article révisé par les pairs
| Résumé : | Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) is poorly defined in cystic fibrosis (CF) patients, and S. aureus detection may be hampered by the presence of small colony variants (SCVs). We conducted a multicentre survey to determine the prevalence of S. aureus and MRSA colonization in Belgian CF patients and characterize the phenotype and clonal distribution of their staphylococcal strains. |
